Example: biology
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 New Zealand Datasheet 1 PRODUCT NAME . ACTRAPID®. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION . Insulin human, rDNA (produced by recombinant DNA technology in Saccharomyces cerevisiae).
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Guidelines for dispensing of medicines - WHO
apps.who.intp. 3 Guidelines for dispensing of medicines • maximising the benefits of the therapy • improving the patient’s understanding of the treatment
NPIS
www.npis.orgEmergency treatment of hydrofluoric acid (HF) burns and injury prior to transfer to hospital Decontamination Decontamination is the immediate priority if the patient is responsive. This takes precedence
ANNEX 3 - UNECE Homepage
www.unece.org- 307 - Annex 3 PRECAUTIONARY STATEMENTS AND PRECAUTIONARY PICTOGRAMS A3.1 Introduction A3.1.1 This annex provides guidance on the use of precautionary statements consistent with the
Developing Analytical Toxicology Services: …
www.who.intDeveloping Analytical Toxicology Services: Principles and Guidance RJ Flanagan PhD SRCS CChem FRSC FRCPath Consultant Clinical Scientist Medical Toxicology Unit, Guy’s & St Thomas’ NHS Foundation Trust, London, UK
Guidelines for Product Recall and Product …
apps.who.intEdited-Final-Recall Guidelines 13 04 2010.doc v1.doc ii Guidelines for Product Recall and Product Withdrawal This document has been prepared to serve as a guide to
Drug Take-back Programs: Safe Disposal of …
www.ncdoi.comDrug Take-back Programs: Safe Disposal of Unused, Expired, or Unwanted Medications in North Carolina Prepared for: Coastal …
The College of Emergency Medicine
www.rcem.ac.ukThe College of Emergency Medicine Patron: HRH The Princess Royal 7-9 Breams Buildings Tel +44 (0)207 404 1999 London Fax +44 (0)207 067 1267 EC4A 1DT www.collemergencymed.ac.uk Excellence in Emergency Care Incorporated by Royal Charter, 2008 • Registered Charity number 1122689 3rd September 2012 Dear …
Related search queries
Guidelines for dispensing of medicines, Treatment, NPIS, Annex 3, Guidance, Developing Analytical Toxicology Services:, Developing Analytical Toxicology Services: Principles and Guidance, Guidelines for Product Recall and Product, Guidelines for Product Recall and Product Withdrawal, Take-back Programs: Safe Disposal of, Take-back Programs: Safe Disposal of Unused, The College of Emergency Medicine